GSK vs PHIN · P/E 13, $103.31B cap vs P/E 27, rev $3.48B
GlaxoSmithKline PLC ADR (GSK) versus PHINIA Inc. (PHIN) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
PHINIA Inc. (PHIN) is a auto parts company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported PHIN revenue for 2025-12-31 was $3.48B. Net income was $130.0M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. PHIN currently screens at market cap $1.88B and trailing P/E 26.8.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. PHIN currently screens at market cap $1.88B and trailing P/E 26.8.
Not investment advice. Open the GSK and PHIN stock pages for the full models.
Not investment advice.